G
Gregory A. Masters
Researcher at Christiana Care Health System
Publications - 90
Citations - 7775
Gregory A. Masters is an academic researcher from Christiana Care Health System. The author has contributed to research in topics: Lung cancer & Carboplatin. The author has an hindex of 28, co-authored 76 publications receiving 5960 citations. Previous affiliations of Gregory A. Masters include University of Pennsylvania & NorthShore University HealthSystem.
Papers
More filters
Journal ArticleDOI
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D. Bradley,Rebecca Paulus,Ritsuko Komaki,Gregory A. Masters,George R. Blumenschein,Steven E. Schild,Jeffrey A. Bogart,Chen Hu,Kenneth M. Forster,Anthony M. Magliocco,V.S. Kavadi,Yolanda I. Garces,Samir Narayan,Puneeth Iyengar,Cliff G. Robinson,Raymond B. Wynn,Christopher Koprowski,Joanne Meng,Jonathan J. Beitler,Rakesh Gaur,Walter J. Curran,Hak Choy +21 more
TL;DR: Overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the addition of cetuximab to concurrent chemoradiation for patients with inoperable stage III non-small-cell lung cancer was compared.
Journal ArticleDOI
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gregory A. Masters,Sarah Temin,Christopher G. Azzoli,Giuseppe Giaccone,Sherman Baker,Julie R. Brahmer,Peter M. Ellis,Ajeet Gajra,Nancy Rackear,Joan H. Schiller,Thomas J. Smith,John R. Strawn,David Trent,David H. Johnson +13 more
TL;DR: This guideline update reflects changes in evidence since the previous guideline and recommends combination cytotoxic chemotherapy is recommended, guided by histology, with early concurrent palliative care.
Journal ArticleDOI
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
Jyoti D. Patel,Lada Krilov,Sylvia Adams,Carol Aghajanian,Ethan Basch,Marcia S. Brose,William L. Carroll,Marcos de Lima,Mark R. Gilbert,Mark G. Kris,John L. Marshall,Gregory A. Masters,Steven J. O'Day,Blase N. Polite,Gary K. Schwartz,Sunil Sharma,Ian M. Thompson,Nicholas J. Vogelzang,Bruce J. Roth +18 more
TL;DR: Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology represents the invaluable contributions of thousands of patients who participate in clinical trials and the scientists who conduct basic and clinical research.
Journal ArticleDOI
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
TL;DR: This guideline update reflects changes in evidence since the previous guideline and recommends combination cytotoxic chemotherapy is recommended, guided by histology, with early concurrent palliative care.
Journal ArticleDOI
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
Thomas Condamine,George A. Dominguez,Je-In Youn,Andrew V. Kossenkov,Sridevi Mony,Kevin Alicea-Torres,Evgenii N. Tcyganov,Ayumi Hashimoto,Yulia Nefedova,Cindy Lin,Simona Partlova,Alfred L. Garfall,Dan T. Vogl,Xiaowei Xu,Stella C. Knight,George Malietzis,Gui Han Lee,Evgeniy Eruslanov,Steven M. Albelda,Xianwei Wang,Jawahar L. Mehta,Meenakshi Bewtra,Anil K. Rustgi,Neil Hockstein,Robert L Witt,Gregory A. Masters,Brian Nam,Denis Smirnov,Manuel A. Sepulveda,Dmitry I. Gabrilovich +29 more
TL;DR: A specific marker of human PMN-MDSC associated with ER stress and lipid metabolism is identified, which provides new insights into the biology and potential therapeutic targeting of these cells.